Skip to main content

Table 2 Patients’ Characteristics

From: Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19

Patient Severe (n = 5) Critical (n = 10) p-value
Age (year-old; median (IQR)) 73 (57-75) 73 (67-78) 0.8537
Gender (Male: %) 40% 70% 0.3286
BMI (median (IQR)) 22.8 (22-24) 25.6 (23-28) 0.4990
First Symptom (%)
 dyspnea 40 20 0.5604
 fever 75 80 0.5604
 cough 20 20 1.0000
 others 40 20 0.5604
Smoking History (%) 75 40 0.6084
Admission day after onset (day; median (IQR)) 3 (2-3) 7 (6-8) 0.0160
Complications (%)
 Diabetes 40 60 0.6084
 Renal Dysfunction 20 10 1.0000
 Hemodialysis 20 10 1.0000
 Hypertension 40 40 1.0000
 Hyperlipidemia 0 10 1.0000
 Hyperuricemia 0 20 0.5238
 Cardiovascular Disease 20 0 0.6084
 Respiratory Disease 75 20 0.2507
 Cancer 20 10 1.0000
 Collagen Disease 20 0 0.3333
 Thrombotic disease 0 0 1.0000
 others 2 0 0.0952
APACHE II Score (pts; median (IQR) 5 (5-8) 5 (5-10) 0.2313
  1. *Mann-Whitney U test or Fisher’s exact test; IQR interquartile range, BMI Body Mass Index